BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16542837)

  • 1. First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.
    Burdi R; Didonna MP; Pignol B; Nico B; Mangieri D; Rolland JF; Camerino C; Zallone A; Ferro P; Andreetta F; Confalonieri P; De Luca A
    Neuromuscul Disord; 2006 Apr; 16(4):237-48. PubMed ID: 16542837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
    De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice.
    De Luca A; Nico B; Liantonio A; Didonna MP; Fraysse B; Pierno S; Burdi R; Mangieri D; Rolland JF; Camerino C; Zallone A; Confalonieri P; Andreetta F; Arnoldi E; Courdier-Fruh I; Magyar JP; Frigeri A; Pisoni M; Svelto M; Conte Camerino D
    Am J Pathol; 2005 Feb; 166(2):477-89. PubMed ID: 15681831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
    Taniguti AP; Pertille A; Matsumura CY; Santo Neto H; Marques MJ
    Muscle Nerve; 2011 Jan; 43(1):82-7. PubMed ID: 21108244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice.
    Dupont-Versteegden EE; McCarter RJ
    Muscle Nerve; 1992 Oct; 15(10):1105-10. PubMed ID: 1406767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
    Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
    Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
    Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach.
    Pierno S; Nico B; Burdi R; Liantonio A; Didonna MP; Cippone V; Fraysse B; Rolland JF; Mangieri D; Andreetta F; Ferro P; Camerino C; Zallone A; Confalonieri P; De Luca A
    Neuropathol Appl Neurobiol; 2007 Jun; 33(3):344-59. PubMed ID: 17493014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
    Gosselin LE; Williams JE
    Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice.
    Spencer MJ; Tidball JG
    Exp Cell Res; 1996 Aug; 226(2):264-72. PubMed ID: 8806430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine.
    De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Simonetti S; Papadia F; Camerino DC
    Br J Pharmacol; 2001 Mar; 132(5):1047-54. PubMed ID: 11226135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle.
    Gosselin LE; Williams JE; Deering M; Brazeau D; Koury S; Martinez DA
    Muscle Nerve; 2004 Nov; 30(5):645-53. PubMed ID: 15389721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
    Bizario JC; Cerri DG; Rodrigues LC; Oliveira GL; Nomizo A; de Araujo DD; Fukuhara PS; Ribeiro JC; de Castro FA; Costa MC
    J Neuroimmunol; 2009 Jul; 212(1-2):93-101. PubMed ID: 19508953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
    Radley HG; Davies MJ; Grounds MD
    Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exercise accelerates the degeneration-regeneration cycle and downregulates insulin-like growth factor-1 in muscle of mdx mice.
    Okano T; Yoshida K; Nakamura A; Sasazawa F; Oide T; Takeda S; Ikeda S
    Muscle Nerve; 2005 Aug; 32(2):191-9. PubMed ID: 15937872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice.
    Wooddell CI; Zhang G; Griffin JB; Hegge JO; Huss T; Wolff JA
    Muscle Nerve; 2010 Apr; 41(4):487-99. PubMed ID: 19813196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests.
    Burdi R; Rolland JF; Fraysse B; Litvinova K; Cozzoli A; Giannuzzi V; Liantonio A; Camerino GM; Sblendorio V; Capogrosso RF; Palmieri B; Andreetta F; Confalonieri P; De Benedictis L; Montagnani M; De Luca A
    J Appl Physiol (1985); 2009 Apr; 106(4):1311-24. PubMed ID: 19131478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of L-arginine benefits mdx skeletal muscle function.
    Barton ER; Morris L; Kawana M; Bish LT; Toursel T
    Muscle Nerve; 2005 Dec; 32(6):751-60. PubMed ID: 16116642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
    Lynch GS; Hinkle RT; Faulkner JA
    Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.